S Jeson Sangaralingham Selected Research

Transforming Growth Factor beta (TGF-beta)

2/2016

Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Jeson Sangaralingham Research Topics

Disease

19	Heart Failure 12/2021 - 12/2011
10	Fibrosis (Cirrhosis) 10/2021 - 02/2011
9	Hypertension (High Blood Pressure) 12/2021 - 12/2010
3	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2015
3	Chronic Renal Insufficiency 12/2015 - 01/2015
3	Cardiomegaly (Heart Hypertrophy) 12/2007 - 03/2003
2	Inflammation (Inflammations) 10/2021 - 05/2017
2	Systolic Heart Failure 04/2021 - 01/2020
2	Myocardial Infarction 01/2021 - 08/2013
2	Hypotension (Low Blood Pressure) 10/2019 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 06/2015
2	Obesity 12/2015 - 01/2015
2	Abdominal Obesity 12/2015 - 01/2015
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2015 - 12/2007
1	Hypertrophy 12/2021
1	Neoplasms (Cancer) 10/2021
1	Atrophy 10/2021
1	Acute Kidney Injury (Acute Renal Failure) 04/2021
1	Renal Insufficiency (Renal Failure) 04/2021
1	Dysbiosis 01/2020
1	Ischemia 10/2019
1	Disease Progression 01/2019
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Atrial Fibrillation 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Infarction (Infarctions) 08/2013
1	Atrial Remodeling 01/2013
1	Proteinuria 01/2012
1	Left Ventricular Dysfunction 01/2012
1	Stroke (Strokes) 12/2011

Drug/Important Bio-Agent (IBA)

11	Atrial Natriuretic Factor (ANF)IBA 12/2021 - 12/2007
8	AldosteroneIBA 01/2018 - 12/2010
7	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2021 - 02/2011
7	Natriuretic PeptidesIBA 10/2019 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 10/2019 - 11/2011
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 12/2011
3	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2021 - 01/2018
3	atrial natriuretic factor receptor AIBA 01/2020 - 01/2019
3	Hormones (Hormone)IBA 01/2020 - 03/2015
2	Angiotensin Receptor AntagonistsIBA 04/2021 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	CRRL269IBA 10/2019 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 05/2017 - 01/2013
2	CollagenIBA 02/2016 - 01/2012
2	CytokinesIBA 02/2016 - 03/2015
2	Guanylate Cyclase (Guanylyl Cyclase)IBA 10/2014 - 01/2014
2	Angiotensin IIIBA 01/2014 - 12/2010
2	Messenger RNA (mRNA)IBA 01/2013 - 03/2003
2	SaltsIBA 12/2007 - 07/2007
2	Estrogens (Estrogen)FDA Link 12/2007 - 07/2007
1	CreatinineIBA 04/2021
1	sacubitrilIBA 01/2020
1	Biological ProductsIBA 01/2020
1	SphingolipidsIBA 01/2020
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2018
1	cenderitideIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Cyclic GMPIBA 01/2018
1	Tissue Inhibitor of MetalloproteinasesIBA 02/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2016
1	EnzymesIBA 02/2016
1	Matrix Metalloproteinases (MMPs)IBA 02/2016
1	LipidsIBA 12/2015
1	crisamicin CIBA 03/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2015
1	Pro-BNP1-108IBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2014
1	Soluble Guanylyl CyclaseIBA 01/2014
1	ReninIBA 05/2013
1	AngiotensinsIBA 05/2013
1	Natriuretic AgentsIBA 01/2013
1	FurinIBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2012
1	pro-brain natriuretic peptide (1-76)IBA 12/2011

Therapy/Procedure

7	Therapeutics 01/2020 - 01/2014
3	Nephrectomy 10/2021 - 01/2012
1	Heart-Assist Devices 10/2014
1	Subcutaneous Infusions 01/2012